BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626
610 results:

  • 1. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
    Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
    Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
    [No Abstract]    [Full Text] [Related]  

  • 2. Renin-Angiotensin Inhibitor, Captopril, Attenuates Growth of Patient-Derived colorectal Liver Metastasis Organoids.
    Riddiough GE; Fifis T; Muralidharan V; Christophi C; Tran BM; Perini MV; Vincan E
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542253
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tissue-location-specific transcription programs drive tumor dependencies in colon cancer.
    Yang L; Tu L; Bisht S; Mao Y; Petkovich D; Thursby SJ; Liang J; Patel N; Yen RC; Largent T; Zahnow C; Brock M; Gabrielson K; Salimian KJ; Baylin SB; Easwaran H
    Nat Commun; 2024 Feb; 15(1):1384. PubMed ID: 38360902
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunohistochemical phenotype of colorectal carcinoma in patients with KRAS mutation and mismatch repair status.
    Tashkova D; Ilieva N; Serteva D; Feodorova Y; Mehterov N; Mollova A; Bachurska S
    Folia Med (Plovdiv); 2023 Jun; 65(3):378-383. PubMed ID: 38351812
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [A Case of Resection of T2N0 Colon cancer with Synchronous Solitary Lung Metastasis].
    Shirai Y; Oshima Y; Ito S; Suzuki M; Fukasawa M; Ishikawa K; Machimura T; Nohara M; Murayama A; Sanada K; Kamochi J; Ikoma Y; Kato Y; Sakata S
    Gan To Kagaku Ryoho; 2024 Jan; 51(1):63-65. PubMed ID: 38247094
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Is proctoscopy sufficient for the evaluation of colorectal anastomosis prior to ileostomy reversal? A nationwide retrospective analysis of the Italian Society of Surgical Oncology colorectal cancer Network Collaborative group (SICO-CCN).
    Manigrasso M; Degiuli M; Maione F; Venetucci P; Roviello F; De Palma GD; Milone M;
    Colorectal Dis; 2024 Mar; 26(3):439-448. PubMed ID: 38229251
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer.
    Fernandez-De-Los-Reyes I; Gomez-Dorronsoro M; Monreal-Santesteban I; Fernandez-Fernandez A; Fraga M; Azcue P; Alonso L; Fernandez-Marlasca B; Suarez J; Cordoba-Iturriagagoitia A; Guerrero-Setas D
    Clin Epigenetics; 2023 Dec; 15(1):193. PubMed ID: 38093305
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metastatic pancreatic cancer with multiple metastases confined to the large intestine: a case report and literature review.
    Omatsu R; Nakano Y; Esaka N; Moriyoshi K; Miyamoto S
    Clin J Gastroenterol; 2024 Feb; 17(1):75-79. PubMed ID: 38038857
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease.
    Musulen E; Gené M; Cuatrecasas M; Amat I; Veiga JA; Fernández-Aceñero MJ; Chimisana VF; Tarragona J; Jurado I; Fernández-Victoria R; Martínez-Ciarpaglini C; Alenda González C; Zac C; Fernández-Figueras MT; Esteller M
    Hum Pathol; 2024 Jan; 143():50-61. PubMed ID: 38000679
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
    Challoner BR; Woolston A; Lau D; Buzzetti M; Fong C; Barber LJ; Anandappa G; Crux R; Assiotis I; Fenwick K; Begum R; Begum D; Lund T; Sivamanoharan N; Sansano HB; Domingo-Arada M; Tran A; Pandha H; Church D; Eccles B; Ellis R; Falk S; Hill M; Krell D; Murugaesu N; Nolan L; Potter V; Saunders M; Shiu KK; Guettler S; Alexander JL; Lázare-Iglesias H; Kinross J; Murphy J; von Loga K; Cunningham D; Chau I; Starling N; Ruiz-Bañobre J; Dhillon T; Gerlinger M
    J Pathol; 2024 Feb; 262(2):226-239. PubMed ID: 37964706
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multivariate Prognostic Models for Patients with Stages I and Ii Colon Carcinoma: a Strobe-Compliant Retrospective Cohort Study.
    Oñate-Ocaña LF; Herrera-Goepfert R; Avilés-Salas A; Cortés CC; González-Trejo S; Carrillo JF; Ruiz-García E; Ochoa-Carrillo FJ; Aiello-Crocifoglio V; García-Cuellar CM
    Rev Invest Clin; 2023; 75(5):259-271. PubMed ID: 37918013
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The risk of bleeding and perforation from sigmoidoscopy or colonoscopy in colorectal cancer screening: A systematic review and meta-analyses.
    Kindt IS; Martiny FHJ; Gram EG; Bie AKL; Jauernik CP; Rahbek OJ; Nielsen SB; Siersma V; Bang CW; Brodersen JB
    PLoS One; 2023; 18(10):e0292797. PubMed ID: 37906565
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The prognostic potential of cdx2 in colorectal cancer: Harmonizing biology and clinical practice.
    Badia-Ramentol J; Gimeno-Valiente F; Duréndez E; Martínez-Ciarpaglini C; Linares J; Iglesias M; Cervantes A; Calon A; Tarazona N
    Cancer Treat Rev; 2023 Dec; 121():102643. PubMed ID: 37871463
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Invasive stratified mucin-producing carcinoma of the colorectum: expanding the morphologic spectrum of large bowel cancer.
    Auld FM; Moyana TN
    Diagn Pathol; 2023 Oct; 18(1):113. PubMed ID: 37853375
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Quantitative dynamic contrast-enhance MRI parameters for rectal carcinoma characterization: correlation with tumor tissue composition.
    Yuan J; Liu K; Zhang Y; Yang Y; Xu H; Han G; Lyu H; Liu M; Tan W; Feng Z; Gong H; Zhan S
    World J Surg Oncol; 2023 Sep; 21(1):306. PubMed ID: 37749564
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Frequent nuclear β-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria.
    Kishikawa S; Hayashi T; Takamochi K; Ura A; Sasahara N; Saito T; Suzuki K; Yao T;
    Virchows Arch; 2023 Nov; 483(5):699-703. PubMed ID: 37740071
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Automating Ground Truth Annotations for Gland Segmentation Through Immunohistochemistry.
    Kataria T; Rajamani S; Ayubi AB; Bronner M; Jedrzkiewicz J; Knudsen BS; Elhabian SY
    Mod Pathol; 2023 Dec; 36(12):100331. PubMed ID: 37716506
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development and validation of a decision tree for distinguishing pulmonary adenocarcinomas with mucinous features and metastatic colorectal adenocarcinoma.
    Wein AN; Lin CY; Ritter JH; Bernadt CT
    Cancer Cytopathol; 2023 Dec; 131(12):781-790. PubMed ID: 37676090
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Time required for indocyanine green fluorescence emission for evaluating bowel perfusion in left-sided colon and rectal cancer surgery.
    Hagiwara C; Wakabayashi T; Tsutsui A; Sakamoto J; Fujita S; Fujiyama Y; Okamoto N; Omura K; Naitoh T; Wakabayashi G
    Surg Endosc; 2023 Oct; 37(10):7876-7883. PubMed ID: 37640952
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Loss of SATB2 and cdx2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer.
    Li J; Zeng Q; Lin J; Huang H; Chen L
    Med Mol Morphol; 2024 Mar; 57(1):1-10. PubMed ID: 37583001
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 31.